Skip to main content
Top
Published in: Hepatology International 2/2015

Open Access 01-04-2015 | Original Article

Association between retinal artery lesions and nonalcoholic fatty liver disease

Authors: Wen Yang, Hongtao Xu, Xiaohong Yu, Yuzhu Wang

Published in: Hepatology International | Issue 2/2015

Login to get access

Abstract

Objective

Retinal artery lesions have been reported to be a risk marker of morbidity and mortality for cardiovascular and cerebrovascular diseases in various study populations. Nonalcoholic fatty liver disease (NAFLD) is also a risk factor for cardiovascular disease. However, the relationship between retinal artery lesions and NAFLD is less certain.

Methods

Data were obtained from 2,454 patients who attended their annual health examination (2,143 males and 311 females, aged 62.34 ± 10.03 years). NAFLD was diagnosed by hepatic ultrasonography. Retinal artery lesions were diagnosed according to the criteria. Total plasma cholesterol, plasma triglyceride and fasting glucose levels were determined by using a multichannel analyzer; the body mass index, systolic blood pressure, diastolic blood pressure, incidence of hypertension and coronary artery disease were measured or analyzed by statistical analysis.

Results

Patients with NAFLD had older age and higher values of BMI, systolic blood pressure, diastolic blood pressure, fasting glucose, total cholesterol and triglycerides and had a higher incidence of hypertension, coronary artery disease and retinal artery lesions (p < 0.01). Retinal artery lesions were taken as a dependent variable, and age, gender, BMI, systolic blood pressure, diastolic blood pressure, fasting glucose, total cholesterol and triglyceride levels, and NAFLD were taken as covariates. We found that age ≥65 years (p < 0.01, OR 1.968), being male (p < 0.01, OR 1.668), BMI ≥ 25 (p < 0.01, OR 0.743), SBP ≥ 140 mmHg (p < 0.01, OR 1.368) and NAFLD (p < 0.01, OR 2.378) were significantly associated with a risk of retinal artery lesions by binary logistic regression analysis.

Conclusions

Patients with NAFLD were older and had higher values for BMI, systolic blood pressure, diastolic blood pressure, fasting glucose, total cholesterol and triglycerides, and higher incidence of hypertension, coronary artery disease and retinal artery lesions. NAFLD is a risk factor for retinal artery lesions.
Literature
1.
go back to reference Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395CrossRefPubMed Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395CrossRefPubMed
2.
go back to reference Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepa-titis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202–1219CrossRefPubMed Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepa-titis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202–1219CrossRefPubMed
3.
go back to reference Salamone F, Bugianesi E. Nonalcoholic fatty liver disease: the he-patic trigger of the metabolic syndrome. J Hepatol. 2010;53:1146–1147CrossRefPubMed Salamone F, Bugianesi E. Nonalcoholic fatty liver disease: the he-patic trigger of the metabolic syndrome. J Hepatol. 2010;53:1146–1147CrossRefPubMed
4.
go back to reference Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis. 2004;24:349–362CrossRefPubMed Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis. 2004;24:349–362CrossRefPubMed
5.
go back to reference Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;65:1415–1428CrossRef Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;65:1415–1428CrossRef
6.
go back to reference Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology. 2005;42:44–52CrossRefPubMed Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology. 2005;42:44–52CrossRefPubMed
7.
go back to reference Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, et al. Fatty liver: an additional and treatable feature of the insulin resistance syndrome. QJM. 1999;92:73–79CrossRefPubMed Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, et al. Fatty liver: an additional and treatable feature of the insulin resistance syndrome. QJM. 1999;92:73–79CrossRefPubMed
8.
go back to reference Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87:3023–3028CrossRefPubMed Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87:3023–3028CrossRefPubMed
9.
go back to reference Zhao Y, Yang K, Wang F, Liang Y, Peng Y, Shen R, et al. Associations between metabolic syndrome and syndrome components and retinal microvascular signs in a rural Chinese population: the Handan Eye Study. Graefe’s Arch Clin Exp Ophthalmol. 2012;250:1755–1763CrossRef Zhao Y, Yang K, Wang F, Liang Y, Peng Y, Shen R, et al. Associations between metabolic syndrome and syndrome components and retinal microvascular signs in a rural Chinese population: the Handan Eye Study. Graefe’s Arch Clin Exp Ophthalmol. 2012;250:1755–1763CrossRef
10.
go back to reference Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, Tano Y, et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol. 2008;92(2):161–166CrossRefPubMed Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, Tano Y, et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol. 2008;92(2):161–166CrossRefPubMed
11.
go back to reference Baker ML, Hand PJ, Wang JJ, Wong TY. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke. 2008;39:1371–1379CrossRefPubMed Baker ML, Hand PJ, Wang JJ, Wong TY. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke. 2008;39:1371–1379CrossRefPubMed
12.
go back to reference Wang JJ, Liew G, Wong TY, Smith W, Klein R, Leeder SR, et al. Retinal vascular calibre and the risk of coronary heart disease-related death. Heart. 2006;92:1583–1587CrossRefPubMedCentralPubMed Wang JJ, Liew G, Wong TY, Smith W, Klein R, Leeder SR, et al. Retinal vascular calibre and the risk of coronary heart disease-related death. Heart. 2006;92:1583–1587CrossRefPubMedCentralPubMed
13.
go back to reference Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;49:600–607CrossRefPubMed Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;49:600–607CrossRefPubMed
14.
go back to reference Kelishadi R, Cook SR, Amra B, et al. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis. 2009;204:538–543CrossRefPubMed Kelishadi R, Cook SR, Amra B, et al. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis. 2009;204:538–543CrossRefPubMed
16.
go back to reference Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166). J Dig Dis. 2011;12:38–44CrossRefPubMed Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166). J Dig Dis. 2011;12:38–44CrossRefPubMed
17.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572CrossRefPubMed
18.
go back to reference Choi SY, Kim D, Kim HJ, Kang JH, Chung SJ, Park MJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol. 2009;104(8):1953–1960CrossRefPubMed Choi SY, Kim D, Kim HJ, Kang JH, Chung SJ, Park MJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol. 2009;104(8):1953–1960CrossRefPubMed
19.
go back to reference Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci. 2011;56(1):35–45CrossRefPubMed Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci. 2011;56(1):35–45CrossRefPubMed
20.
go back to reference Nseir W, Shalata A, Marmor A, Assy N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci. 2011;56(12):3439–3449CrossRefPubMed Nseir W, Shalata A, Marmor A, Assy N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci. 2011;56(12):3439–3449CrossRefPubMed
21.
go back to reference Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol. 2010;24(5):695–708CrossRefPubMed Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol. 2010;24(5):695–708CrossRefPubMed
22.
go back to reference Josef P, Ali I, Ariel P, Alon M, Nimer A. Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). Int J Environ Res Public Health. 2013;10(8):3409–3423CrossRefPubMedCentralPubMed Josef P, Ali I, Ariel P, Alon M, Nimer A. Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). Int J Environ Res Public Health. 2013;10(8):3409–3423CrossRefPubMedCentralPubMed
23.
go back to reference Băloşeanu CL, Streba CT, Vere CC, Comănescu V, Rogoveanu I. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom J Morphol Embryol. 2012;53(3):609–614PubMed Băloşeanu CL, Streba CT, Vere CC, Comănescu V, Rogoveanu I. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom J Morphol Embryol. 2012;53(3):609–614PubMed
24.
go back to reference Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care. 2004;27(10):2498–2500CrossRefPubMed Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care. 2004;27(10):2498–2500CrossRefPubMed
25.
go back to reference Ying X, Jiang Y, Qian Y, Jiang Z, Song Z, Zhao C. Association between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in Chinese adults. Iran J Public Health. 2012;41(1):45–49PubMedCentralPubMed Ying X, Jiang Y, Qian Y, Jiang Z, Song Z, Zhao C. Association between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in Chinese adults. Iran J Public Health. 2012;41(1):45–49PubMedCentralPubMed
26.
go back to reference Daien V, Carriere I, Kawasaki R, Cristol JP, Villain M, Fesler P, et al. Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study. PLoS One. 2013;8(7):e71089CrossRefPubMedCentralPubMed Daien V, Carriere I, Kawasaki R, Cristol JP, Villain M, Fesler P, et al. Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study. PLoS One. 2013;8(7):e71089CrossRefPubMedCentralPubMed
28.
go back to reference Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G. Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler Thromb Vasc Biol. 2005;25(12):2687–2688CrossRefPubMed Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G. Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler Thromb Vasc Biol. 2005;25(12):2687–2688CrossRefPubMed
29.
go back to reference Chew SK, Xie J, Wang JJ. Retinal arteriolar diameter and the prevalence and incidence of hypertension: a systematic review and meta-analysis of their association. Curr Hypertens Rep. 2012;14(2):144–151CrossRefPubMed Chew SK, Xie J, Wang JJ. Retinal arteriolar diameter and the prevalence and incidence of hypertension: a systematic review and meta-analysis of their association. Curr Hypertens Rep. 2012;14(2):144–151CrossRefPubMed
30.
go back to reference Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29–33CrossRefPubMed Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29–33CrossRefPubMed
31.
go back to reference Targher G, Bertolini L, Zenari L. Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects. Diabetes Care. 2004;27(8):2085–2086CrossRefPubMed Targher G, Bertolini L, Zenari L. Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects. Diabetes Care. 2004;27(8):2085–2086CrossRefPubMed
32.
go back to reference Omelchenko E, Gavish D, Shargorodsky M. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. J Am Soc Hypertens. 2014;8(6):376–380CrossRefPubMed Omelchenko E, Gavish D, Shargorodsky M. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. J Am Soc Hypertens. 2014;8(6):376–380CrossRefPubMed
Metadata
Title
Association between retinal artery lesions and nonalcoholic fatty liver disease
Authors
Wen Yang
Hongtao Xu
Xiaohong Yu
Yuzhu Wang
Publication date
01-04-2015
Publisher
Springer India
Published in
Hepatology International / Issue 2/2015
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-015-9607-3

Other articles of this Issue 2/2015

Hepatology International 2/2015 Go to the issue